SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-18-016167
Filing Date
2018-03-21
Accepted
2018-03-21 16:11:43
Documents
1
Group Members
ADAMS STREET 2011 DIRECT FUND LPADAMS STREET 2012 DIRECT FUND LPADAMS STREET 2013 DIRECT FUND LPADAMS STREET 2014 DIRECT FUND LPADAMS STREET 2015 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2016 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2017 DIRECT VENTURE/

Document Format Files

Seq Description Document Type Size
1 SC 13D tv489024_sc13d.htm SC 13D 244488
  Complete submission text file 0001144204-18-016167.txt   246361
Mailing Address ONE NORTH WACKER DRIVE STE 2200 CHICAGO IL 60606-2807
Business Address
ADAMS STREET PARTNERS LLC (Filed by) CIK: 0001193586 (see all company filings)

IRS No.: 364395178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Subject) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89443 | Film No.: 18704552
SIC: 2834 Pharmaceutical Preparations